Mammogram of breast cancer

Dying breast cancer tumors release declining levels of mutant DNA into the blood, unless those tumors are recurring.  And, there is a test for recurrence from Natera (San Carlos, CA).  Its “Signatera” blood test accounts for DNA fragments associated with HER2 positive, hormone receptor-positive, and triple negative breast tumors.  Clinical testing at two centers in England showed 89% accuracy for discovering relapses.    MORE

Image Credit:  Wikimedia commons